Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year net income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-122.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -21.68% |
| Q2 2025 | 3.18% |
| Q1 2025 | -1.52% |
| Q4 2024 | -23.74% |
| Q3 2024 | 13.29% |
| Q2 2024 | 13.92% |
| Q1 2024 | -15.77% |
| Q4 2023 | 6.80% |
| Q3 2023 | 20.31% |
| Q2 2023 | -386.62% |
| Q1 2023 | 159.74% |
| Q4 2022 | 39.27% |
| Q3 2022 | -127.29% |
| Q2 2022 | 463.91% |
| Q1 2022 | -22.72% |
| Q4 2021 | 10.36% |
| Q3 2021 | 11.79% |
| Q2 2021 | -9.32% |
| Q1 2021 | -2.88% |
| Q4 2020 | -3.86% |
| Q3 2020 | 0.18% |
| Q2 2020 | -334.83% |
| Q1 2020 | 135.44% |
| Q4 2019 | -18.05% |
| Q3 2019 | 48.06% |
| Q2 2019 | -10.93% |
| Q1 2019 | 14.93% |
| Q4 2018 | -12.47% |
| Q3 2018 | 4.43% |
| Q2 2018 | 5.12% |
| Q1 2018 | -41.95% |
| Q4 2017 | -125.77% |
| Q3 2017 | 438.43% |
| Q2 2017 | -12.51% |
| Q1 2017 | 33.46% |
| Q4 2016 | 79.17% |
| Q3 2016 | -458.82% |
| Q2 2016 | -8.53% |
| Q1 2016 | 33.91% |
| Q4 2015 | -41.15% |